Tata Ethical Fund
The fund aims to provide medium to long term capital gains by investing in Sharia compliant equity and equity related instruments of well researched value and growth oriented companies.
Growthvine rating: 2/5 — ranked #121 of 184 in category.
Fund basics
| Category | Equity: Thematic |
|---|
| NAV | ₹341.54 (as of 2026-10-01) |
|---|
| AUM | ₹3,861 Cr |
|---|
| Expense ratio | 1.62% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Abhinav Sharma |
|---|
| Exit load | 0.5% for redemption within 90 days |
|---|
Performance & risk
| 5-year annualised return | 4.20% |
|---|
| Sharpe ratio | 0.01 |
|---|
| Standard deviation | 14.71% |
|---|
| Max drawdown | −70.53% |
|---|
| Alpha | -6.1 |
|---|
| Beta | 0.9 |
|---|
Over 5 years, captured 84.1% of NIFTY100 ESG's upside and 88.9% of its downside.
Market cap allocation
| Large cap | 57.3% |
|---|
| Mid cap | 28.7% |
|---|
| Small cap | 14.1% |
|---|
Concentration
| Top 5 holdings | 22.9% |
|---|
| Top 10 holdings | 36.3% |
|---|
| Total holdings | 56 |
|---|
Top holdings
- Infosys Ltd — 7.3%
- Tata Consultancy Services Ltd. — 5.8%
- CASH / NET CURRENT ASSET — 3.7%
- Tech Mahindra Limited — 3.7%
- HCL Technologies Ltd — 3.2%
- Dr. Reddys Laboratories Ltd. — 3.0%
- Bharat Heavy Electricals Ltd. — 2.9%
- Hindustan Unilever Ltd. — 2.9%
- JINDAL STEEL LIMITED — 2.8%
- UltraTech Cement Ltd — 2.4%
Top sectors
- Software & Services — 28.0%
- Pharma & Biotech — 11.4%
- Automobile — 9.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −12.2% | Q4 (Bottom) | #159 of 167 |
| 2025 | −1.3% | Q4 (Bottom) | #103 of 132 |
| 2024 | 13.2% | Q4 (Bottom) | #74 of 86 |
| 2023 | 26.7% | Q3 | #44 of 66 |
| 2022 | −6.5% | Q4 (Bottom) | #48 of 55 |